“This is another key milestone as we expand our reach to the UK following successful approval across Europe for our innovative infertility and cancer detection products.” stated Kathy Lee-Sepsick, ...
ATLANTA - Femasys Inc. (NASDAQ:FEMY), a biomedical company specializing in women's health, has announced the UK regulatory approval of three of its products: the FemaSeed Intratubal Insemination ...
Cervical cancer is a disease in which the cells of the cervix become abnormal and start to grow uncontrollably. Approximately 90% are squamous cell carcinomas, and the remaining 10% are ...
With proper screening, vaccination, and awareness, we can significantly reduce cervical cancer cases. It is crucial to educate people because cervical cancer is one of the few cancers in women ...
February marks Cancer Prevention Awareness Month, and local doctors are stressing the importance of early detection and prevention for two cancers that impact women: cervical and ovarian cancer.
Femasys has gained approval for its FemaSeed Intratubal Insemination product and two diagnostic devices from the Ministry of ...
February marks Cancer Prevention Awareness Month, and local doctors are stressing the importance of early detection and prevention for two cancers that impact women: cervical and ovarian cancer.
It is the first time in the state that we have started free cancer screening across Jharkhand at all government health centers for early detection and treatment of the disease,' said Ansari ...
Ranchi: Jharkhand health minister Irfan Ansari on Tuesday announced that 42,000 sahiyas (community health workers) will ...
Ketone Drink May Benefit Heart Health in Type 2 Diabetes: Study FindsDrinking ketones improves heart health, a new ...
PORTLAND, OR, UNITED STATES, February 8, 2025 /EINPresswire / -- The global women's health diagnostics market is experiencing rapid expansion, driven by technological advancements, increased health ...
Although common, the cause of these hernias is unknown, and the only treatment ... Cancer Vaccine Shows Promise for Patients With Stage III and IV Kidney Cancer Feb. 5, 2025 — Researchers report ...